171 related articles for article (PubMed ID: 35014812)
1. Combined Ibuprofen and Curcumin Delivery Using Mg-MOF-74 as a Single Nanocarrier.
Lawson S; Rownaghi AA; Rezaei F
ACS Appl Bio Mater; 2022 Jan; 5(1):265-271. PubMed ID: 35014812
[TBL] [Abstract][Full Text] [Related]
2. Curcumin Delivery on Metal-Organic Frameworks: The Effect of the Metal Center on Pharmacokinetics within the M-MOF-74 Family.
Lawson S; Newport K; Pederniera N; Rownaghi AA; Rezaei F
ACS Appl Bio Mater; 2021 Apr; 4(4):3423-3432. PubMed ID: 35014426
[TBL] [Abstract][Full Text] [Related]
3. Mixing Mg-MOF-74 with Zn-MOF-74: A Facile Pathway of Controlling the Pharmacokinetic Release Rate of Curcumin.
Lawson S; Siemers A; Kostlenick J; Al-Naddaf Q; Newport K; Rownaghi AA; Rezaei F
ACS Appl Bio Mater; 2021 Sep; 4(9):6874-6880. PubMed ID: 35006987
[TBL] [Abstract][Full Text] [Related]
4. Drug Delivery on Mg-MOF-74: The Effect of Drug Solubility on Pharmacokinetics.
Pederneira N; Newport K; Lawson S; Rownaghi AA; Rezaei F
ACS Appl Bio Mater; 2023 Jun; 6(6):2477-2486. PubMed ID: 37289462
[TBL] [Abstract][Full Text] [Related]
5. Optimizing ibuprofen concentration for rapid pharmacokinetics on biocompatible zinc-based MOF-74 and UTSA-74.
Lawson S; Newport K; Schueddig K; Rownaghi AA; Rezaei F
Mater Sci Eng C Mater Biol Appl; 2020 Dec; 117():111336. PubMed ID: 32919685
[TBL] [Abstract][Full Text] [Related]
6. Performance of MIL-101(Cr) and MIL-101(Cr)-Pore Expanded as Drug Carriers for Ibuprofen and 5-Fluorouracil Delivery.
Pederneira N; Aina PO; Rownaghi AA; Rezaei F
ACS Appl Bio Mater; 2024 Feb; 7(2):1041-1051. PubMed ID: 38190506
[TBL] [Abstract][Full Text] [Related]
7. Enhanced Drug Delivery by Dissolution of Amorphous Drug Encapsulated in a Water Unstable Metal-Organic Framework (MOF).
Suresh K; Matzger AJ
Angew Chem Int Ed Engl; 2019 Nov; 58(47):16790-16794. PubMed ID: 31550411
[TBL] [Abstract][Full Text] [Related]
8. New metal-organic framework coated sodium alginate for the delivery of curcumin as a sustainable drug delivery and cancer therapy system.
Nabipour H; Aliakbari F; Volkening K; Strong MJ; Rohani S
Int J Biol Macromol; 2024 Feb; 259(Pt 1):128875. PubMed ID: 38154719
[TBL] [Abstract][Full Text] [Related]
9. Recent Advances in Metal-Organic Frameworks as Anticancer Drug Delivery Systems: A Review.
Karami A; Mohamed O; Ahmed A; Husseini GA; Sabouni R
Anticancer Agents Med Chem; 2021; 21(18):2487-2504. PubMed ID: 33463479
[TBL] [Abstract][Full Text] [Related]
10. Breast Cancer Targeting of a Drug Delivery System through Postsynthetic Modification of Curcumin@N
Alves RC; Schulte ZM; Luiz MT; Bento da Silva P; Frem RCG; Rosi NL; Chorilli M
Inorg Chem; 2021 Aug; 60(16):11739-11744. PubMed ID: 34101467
[TBL] [Abstract][Full Text] [Related]
11. A γ-cyclodextrin-based metal-organic framework (γ-CD-MOF): a review of recent advances for drug delivery application.
Hamedi A; Anceschi A; Patrucco A; Hasanzadeh M
J Drug Target; 2022 Apr; 30(4):381-393. PubMed ID: 34847807
[TBL] [Abstract][Full Text] [Related]
12. Composite CD-MOF nanocrystals-containing microspheres for sustained drug delivery.
Li H; Lv N; Li X; Liu B; Feng J; Ren X; Guo T; Chen D; Fraser Stoddart J; Gref R; Zhang J
Nanoscale; 2017 Jun; 9(22):7454-7463. PubMed ID: 28530283
[TBL] [Abstract][Full Text] [Related]
13. Novel γ-cyclodextrin-metal-organic frameworks for encapsulation of curcumin with improved loading capacity, physicochemical stability and controlled release properties.
Chen Y; Tai K; Ma P; Su J; Dong W; Gao Y; Mao L; Liu J; Yuan F
Food Chem; 2021 Jun; 347():128978. PubMed ID: 33444890
[TBL] [Abstract][Full Text] [Related]
14. Functionalization of β-cyclodextrin metal-organic frameworks with gelatin and glutamine for drug delivery of curcumin to cancerous cells.
Sadeh P; Zeinali S; Rastegari B; Najafipour I
Heliyon; 2024 May; 10(9):e30349. PubMed ID: 38726172
[TBL] [Abstract][Full Text] [Related]
15. Merging metal organic framework with hollow organosilica nanoparticles as a versatile nanoplatform for cancer theranostics.
Chen L; Zhang J; Zhou X; Yang S; Zhang Q; Wang W; You Z; Peng C; He C
Acta Biomater; 2019 Mar; 86():406-415. PubMed ID: 30625415
[TBL] [Abstract][Full Text] [Related]
16. Metal-organic frameworks (MOFs) as host materials for the enhanced delivery of biomacromolecular therapeutics.
Tong PH; Zhu L; Zang Y; Li J; He XP; James TD
Chem Commun (Camb); 2021 Nov; 57(91):12098-12110. PubMed ID: 34714306
[TBL] [Abstract][Full Text] [Related]
17. One-pot synthesis of Eu-MOFs for bioimaging and drug delivery.
Zhang Q; Li J; Zu W; Yang H; Wang Y
Drug Dev Ind Pharm; 2021 Jul; 47(7):1175-1182. PubMed ID: 34612119
[TBL] [Abstract][Full Text] [Related]
18. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.
Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ
Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060
[TBL] [Abstract][Full Text] [Related]
19. Constructing Redox-Responsive Metal-Organic Framework Nanocarriers for Anticancer Drug Delivery.
Lei B; Wang M; Jiang Z; Qi W; Su R; He Z
ACS Appl Mater Interfaces; 2018 May; 10(19):16698-16706. PubMed ID: 29692177
[TBL] [Abstract][Full Text] [Related]
20. Metal-Organic Frameworks for Drug Delivery: A Design Perspective.
Lawson HD; Walton SP; Chan C
ACS Appl Mater Interfaces; 2021 Feb; 13(6):7004-7020. PubMed ID: 33554591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
